Seattle, WA, United States of America

Jeannette Nussbaum

This inventor holds 1 USPTO granted patent. Top assignee: Nanostring Technologies, Inc.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeannette Nussbaum. Retrieved from https://idiyas.com/inventor/jeannette-nussbaum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeannette Nussbaum: Innovator in Cancer Diagnostics

Introduction

Jeannette Nussbaum is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of cancer diagnostics, particularly in the detection of leukemia. Her innovative work has the potential to improve the lives of many patients through early diagnosis and treatment.

Latest Patents

Jeannette holds 1 patent for her invention titled "Compositions and methods for diagnosing cancer." This patent describes methods for diagnosing subjects with leukemia by detecting fusion genes associated with the onset of the disease. Her research is crucial in advancing the understanding and treatment of leukemia.

Career Highlights

Jeannette is currently employed at NanoString Technologies, Inc., where she continues to work on groundbreaking projects in cancer diagnostics. Her role at the company allows her to collaborate with other experts in the field and contribute to innovative solutions for cancer detection.

Collaborations

Jeannette has worked alongside notable colleagues, including Philippa Jane Webster and Richard Kemble Boykin. Their combined expertise fosters a collaborative environment that enhances the development of new diagnostic methods.

Conclusion

Jeannette Nussbaum's contributions to cancer diagnostics exemplify the impact of innovation in healthcare. Her work not only advances scientific knowledge but also holds the promise of improving patient outcomes in the fight against leukemia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…